Company / Capital Expenditures
Immunocore Holdings plc Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.3M
FY2025
5-year range
$1.4M / $5.4M
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
#77 of 194
Health Care
What the data says
At $4M, Immunocore Holdings plc's capital expenditures ranks #77 of 194 in the Health Care sector. Declined from $5M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of +25.4%.
Declined from $5M to $4M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +25.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 194 in Health CareTop 40% of 194This company $4.3M Sector average $117.5M
▼
-96.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +25.4%, indicating consistent growth.
- In FY2025, capital expenditures decreased 16.1% year-over-year.
- Ranks #77 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.3M | -16.1% |
| FY2024 | $5.2M | -4.6% |
| FY2023 | $5.4M | +146.3% |
| FY2022 | $2.2M | +58.9% |
| FY2021 | $1.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026